Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrin Signaling in Cancer Cell Survival and Chemoresistance
Fawzi Aoudjit, Kristiina Vuori
Chemotherapy Research and Practice (2012) Vol. 2012, pp. 1-16
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Khalid O. Alfarouk, C C Stock, Sophie Taylor, et al.
Cancer Cell International (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 585
Intravascular Survival and Extravasation of Tumor Cells
Boris Strilić, Stefan Offermanns
Cancer Cell (2017) Vol. 32, Iss. 3, pp. 282-293
Open Access | Times Cited: 349
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
Carrie J. Lovitt, Todd Shelper, Vicky M. Avery
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 302
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
Özge Saatci, Aysegül Kaymak, Umar Raza, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 270
PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
Hatem Soliman, Farah Khalil, Scott Antonia
PLoS ONE (2014) Vol. 9, Iss. 2, pp. e88557-e88557
Open Access | Times Cited: 236
Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
Florence Schaffner, Anne‐Marie Ray, Monique Dontenwill
Cancers (2013) Vol. 5, Iss. 1, pp. 27-47
Open Access | Times Cited: 183
Collagen VI in cancer and its biological mechanisms
Peiwen Chen, Matilde Cescon, Paolo Bonaldo
Trends in Molecular Medicine (2013) Vol. 19, Iss. 7, pp. 410-417
Closed Access | Times Cited: 164
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer
Ye Hu, Hao-Yan Chen, Chen-Yang Yu, et al.
Oncotarget (2014) Vol. 5, Iss. 8, pp. 2230-2242
Open Access | Times Cited: 160
Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening
Shurong Hou, Hervé Tiriac, Banu Priya Sridharan, et al.
SLAS DISCOVERY (2018) Vol. 23, Iss. 6, pp. 574-584
Open Access | Times Cited: 148
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
José Alexandre Ferreira, Andreia Peixoto, Manuel Neves, et al.
Drug Resistance Updates (2015) Vol. 24, pp. 34-54
Open Access | Times Cited: 143
Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix
Noor Jailkhani, Jessica R. Ingram, Mohammad Rashidian, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 28, pp. 14181-14190
Open Access | Times Cited: 142
Function of cancer cell-derived extracellular matrix in tumor progression
Gaofeng Xiong, Ren Xu
Journal of Cancer Metastasis and Treatment (2016) Vol. 2, Iss. 9, pp. 357-357
Open Access | Times Cited: 126
Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies
Daniela Augsburger, Peter J. Nelson, Thomas Kalinski, et al.
Oncotarget (2017) Vol. 8, Iss. 61, pp. 104638-104653
Open Access | Times Cited: 117
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells
Mingyang Liu, Yu‐Qing Zhang, Jingxuan Yang, et al.
Gastroenterology (2019) Vol. 158, Iss. 3, pp. 679-692.e1
Open Access | Times Cited: 105
Alpha2beta1 integrin in cancer development and chemoresistance
Dalila Naci, Kristiina Vuori, Fawzi Aoudjit
Seminars in Cancer Biology (2015) Vol. 35, pp. 145-153
Closed Access | Times Cited: 102
Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance
Hassan Yousefi, Mousa Vatanmakanian, Mojdeh Mahdiannasser, et al.
Oncogene (2021) Vol. 40, Iss. 6, pp. 1043-1063
Open Access | Times Cited: 100
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway
S. C. Tripathi, Johannes F. Fahrmann, Müge Çeliktaş, et al.
Cancer Research (2017) Vol. 77, Iss. 16, pp. 4414-4425
Open Access | Times Cited: 98
Tumor–Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure
Elke Pogge von Strandmann, Silke Reinartz, Uwe Wager, et al.
Trends in cancer (2017) Vol. 3, Iss. 2, pp. 137-148
Open Access | Times Cited: 97
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
Anne-Florence Blandin, Guillaume Renner, Maxime Lehmann, et al.
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 94
Targeting fibronectin for cancer imaging and therapy
Zheng Han, Zheng‐Rong Lu
Journal of Materials Chemistry B (2016) Vol. 5, Iss. 4, pp. 639-654
Open Access | Times Cited: 94
Extracellular Matrix Dynamics as an Emerging yet Understudied Hallmark of Aging and Longevity
Cyril Statzer, Ji Young Cecilia Park, Collin Y. Ewald
Aging and Disease (2023) Vol. 14, Iss. 3, pp. 670-670
Open Access | Times Cited: 40
Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs
Ying Huang, Xiang Yang, Tian‐Rui Xu, et al.
International Journal of Oncology (2016) Vol. 49, Iss. 1, pp. 153-163
Open Access | Times Cited: 84
Role of Integrin Alpha4 in Drug Resistance of Leukemia
Stephanie N. Shishido, Halvard Bönig, Yong‐Mi Kim
Frontiers in Oncology (2014) Vol. 4
Open Access | Times Cited: 79
Addressing intra-tumoral heterogeneity and therapy resistance
Brad Rybinski, Kyuson Yun
Oncotarget (2016) Vol. 7, Iss. 44, pp. 72322-72342
Open Access | Times Cited: 77
Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro†
Sachiko Matsuzaki, Claude Darcha
Human Reproduction (2015) Vol. 30, Iss. 7, pp. 1606-1616
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top